Home > Financial Ratios > CONCORD DRUGS

CONCORD DRUGS
Working Capital/Sales

    Back to All Ratios
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 3.102.722.383.23

What is the latest Working Capital/Sales ratio of CONCORD DRUGS ?

The latest Working Capital/Sales ratio of CONCORD DRUGS is 3.10 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20253.10
Mar20242.72
Mar20232.38
Mar20223.23

How is Working Capital/Sales of CONCORD DRUGS Trending?

Years Working Capital/Sales % Change
Mar2025 3.1
13.97
Mar2024 2.72
14.29
Mar2023 2.38
-26.32
Mar2022 3.23 -

Other Financial Ratios of CONCORD DRUGS


Compare Working Capital/Sales ratio of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹105.2 Cr -0.8% 6.4% 24.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -1.9% -3.7% 18.9% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 2.6% 11.1% 56% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr 0.2% 1.3% 38% Stock Analytics
CIPLA ₹110,515.0 Cr -1.5% -6.4% -12.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -1% -5.1% -8.1% Stock Analytics


CONCORD DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

-0.8%

6.4%

24.9%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses